- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Volume 2012 (2012), Article ID 126906, 11 pages
Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor
1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Mattel Children's Hospital and Gwynne Hazen Cherry Memorial Laboratories, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095-1781, USA
2NanoValent Pharmaceuticals Inc., Bozeman, MT 59718-4012, USA
3Department of Biomathematics, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-1766, USA
4Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA 90095-1770, USA
5Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA 90027, USA
6Department of Anesthesia and Perioperative Cave, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94110, USA
Received 5 June 2012; Accepted 3 July 2012
Academic Editor: Norman Jaffe
Copyright © 2012 Noah Federman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. G. Huvos, Bone Tumors: Diagnosis, Treatment, and Prognosis, WB Saunders, Philadelphia, Pa, USA, 1991.
- D. C. Dahlin and K. K. Unni, “Osteosarcoma of bone and its important recognizable varieties,” American Journal of Surgical Pathology, vol. 1, no. 1, pp. 61–72, 1977.
- J. G. Gurney, A. R. Swensen, and M. Bulterys, “Malignant bone tumors,” in Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995, pp. 99–110, SEER program, National Cancer Institute, Bethesda, Md, USA, 1999.
- K. A. Janeway and H. E. Grier, “Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects,” The Lancet Oncology, vol. 11, no. 7, pp. 670–678, 2010.
- A. Puri, K. Loomis, B. Smith et al., “Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 26, no. 6, pp. 523–580, 2009.
- L. H. Lindner and M. Hossann, “Factors affecting drug release from liposomes,” Current Opinion in Drug Discovery and Development, vol. 13, no. 1, pp. 111–123, 2010.
- T. L. Andresen, S. S. Jensen, and K. Jørgensen, “Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release,” Progress in Lipid Research, vol. 44, no. 1, pp. 68–97, 2005.
- T. M. Allen, “Ligand-targeted therapeutics in anticancer therapy,” Nature Reviews Cancer, vol. 2, no. 10, pp. 750–763, 2002.
- G. W. M. Swart, “Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration,” European Journal of Cell Biology, vol. 81, no. 6, pp. 313–321, 2002.
- S. F. Ofori-Acquah and J. A. King, “Activated leukocyte cell adhesion molecule: a new paradox in cancer,” Translational Research, vol. 151, no. 3, pp. 122–128, 2008.
- G. Kristiansen, C. Pilarsky, C. Wissmann et al., “ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions,” Prostate, vol. 54, no. 1, pp. 34–43, 2003.
- J. A. King, S. F. Ofori-Acquah, T. Stevens, A. B. Al-Mehdi, O. Fodstad, and W. G. Jiang, “Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator,” Breast Cancer Research, vol. 6, no. 5, pp. R478–R487, 2004.
- B. Liu, A. Roth, D. C. Drummond et al., “Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells,” Molecular Cancer Therapeutics, vol. 6, no. 10, pp. 2737–2746, 2007.
- R. E. Bruehl, F. Dasgupta, T. R. Katsumoto et al., “Polymerized liposome assemblies: bifunctional macromolecular selectin inhibitors mimicking physiological selectin ligands,” Biochemistry, vol. 40, no. 20, pp. 5964–5974, 2001.
- J. M. D. T. Nelissen, R. Torensma, M. Pluyter et al., “Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS,” Experimental Hematology, vol. 28, no. 4, pp. 422–432, 2000.
- J. Olmsted and M. Strand, “Fluorescence of polymerized diacetylene bilayer films,” Journal of Physical Chemistry, vol. 87, no. 24, pp. 4790–4792, 1983.
- H. Eckhardt, D. S. Boudreaux, and R. R. Chance, “Effects of substituent-induced strain on the electronic structure of polydiacetylenes,” The Journal of Chemical Physics, vol. 85, no. 7, pp. 4116–4119, 1986.
- B. Liu, F. Conrad, A. Roth, D. C. Drummond, J. P. Simko, and J. D. Marks, “Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer,” Journal of Molecular Medicine, vol. 85, no. 10, pp. 1113–1123, 2007.
- K. E. McCabe, B. Liu, J. D. Marks, J. S. Tomlinson, H. Wu, and A. M. Wu, “An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors,” Molecular Imaging and Biology, vol. 14, no. 3, pp. 336–347, 2012.
- B. Barat, S. J. Sirk, K. E. McCabe et al., “Cys-diabody quantum dot conjugates (ImmunoQdots) for cancer marker detection,” Bioconjugate Chemistry, vol. 20, no. 8, pp. 1474–1481, 2009.
- G. Haran, R. Cohen, L. K. Bar, and Y. Barenholz, “Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases,” Biochimica et Biophysica Acta, vol. 1151, no. 2, pp. 201–215, 1993.
- T. Ishida, M. J. Kirchmeier, E. H. Moase, S. Zalipsky, and T. M. Allen, “Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells,” Biochimica et Biophysica Acta, vol. 1515, no. 2, pp. 144–158, 2001.
- M. A. Bowen and A. Aruffo, “Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions,” Transplantation Proceedings, vol. 31, no. 1-2, pp. 795–796, 1999.
- L. C. L. T. van Kempen, J. J. van den Oord, G. N. P. van Muijen, U. H. Weidle, H. P. J. Bloemers, and G. W. M. Swart, “Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin,” American Journal of Pathology, vol. 156, no. 3, pp. 769–774, 2000.
- E. C. M. Cabral, P. T. Hennies, C. R. D. Correia, R. L. Zollner, and M. H. A. Santana, “Preparation and characterization of diacetylene polymerized liposomes for detection of autoantibodies,” Journal of Liposome Research, vol. 13, no. 3-4, pp. 199–211, 2003.
- D. A. Sipkins, D. A. Cheresh, M. R. Kazemi, L. M. Nevin, M. D. Bednarski, and K. C. P. Li, “Detection of tumor angiogenesis in vivo by α(v)β3-targeted magnetic resonance imaging,” Nature Medicine, vol. 4, no. 5, pp. 623–626, 1998.
- C. Guo, S. Liu, Z. Dai, C. Jiang, and W. Y. Li, “Polydiacetylene vesicles as a novel drug sustained-release system,” Colloids and Surfaces B, vol. 76, no. 1, pp. 362–365, 2010.
- A. Puri, A. Yavlovich, A. Singh, and R. Blumenthal, “A novel class of photo-triggerable liposomes containing DPPC:DC 8,9PC as vehicles for delivery of doxorubcin to cells,” Biochimica et Biophysica Acta, vol. 1808, no. 1, pp. 117–126, 2011.
- Z. Li, G. T. Qin, R. M. Xia et al., “Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery,” Nanotechnology, vol. 22, no. 15, Article ID 155605, 2011.
- D. E. L. de Menezes, M. J. Kirchmeier, J. F. Gagne, L. M. Pilarski, and T. M. Allen, “Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells,” Journal of Liposome Research, vol. 9, no. 2, pp. 199–228, 1999.
- J. M. Moran-Mirabal, D. M. Aubrecht, and H. G. Craighead, “Phase separation and fractal domain formation in phospholipid/diacetylene-supported lipid bilayers,” Langmuir, vol. 23, no. 21, pp. 10661–10671, 2007.
- C. M. F. Gomes, H. van Paassen, S. Romeo et al., “Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies,” Nuclear Medicine and Biology, vol. 33, no. 7, pp. 831–840, 2006.